Trial NCT01853228

View at ClinicalTrials.gov 
Org. Study IDs: CR102071
Secondary IDs: 2013-000390-70 DACOGENAML2004

Last trial update was posted on 2019-06-17

MeSH Interventions

Cytarabine Decitabine

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

EMA/PDCO acknowledged that available results from this study do not support further clinical studies in relapsed/refractory AML paediatric patients.

Limitations And Caveats

The Sponsor terminated the study earlier than planned due to lack of efficacy with 8 evaluable participants in Phase 2 with no clinically meaningful anti-leukemic activity.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID